Search results for "Graft"

showing 10 items of 907 documents

Allogeneic Stem Cell Transplantation for Acquired Aplastic Anemia: Better Outcome with Bone Marrow as Compared to Peripheral Blood in HLA-Matched Sib…

2009

Abstract Abstract 876 Background: Transplantation of bone marrow (BM) from a HLA-matched sibling donor is an effective treatment for severe aplastic anemia (AA) with long-term survival in excess of 80%. In the recent years there were two trends in allogeneic stem cell transplantation (SCT) for AA: (1) increasing proportion of transplants performed from matched unrelated donors (MUD) and (2) increasing proportion of transplants using peripheral blood progenitor cells (PBSC) as stem cell source instead of BM. A similar switch to PBSC over BM grafts is reported in leukemia transplants. PBSC grafts for leukemia are associated with higher rates of chronic graft-versus-host disease (cGVHD). This …

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologyHazard ratioImmunosuppressionCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologySurgeryTransplantationLeukemiasurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureInternal medicineparasitic diseasesmedicineBone marrowAplastic anemiabusinessBlood
researchProduct

Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocy…

2018

Relapse of acute leukemia (AL) after allogeneic hematopoietic cell transplantation (Allo-HCT) entails a dismal prognosis. In this scenario, donor lymphocyte infusions (DLIs) and second Allo-HCT are two major approaches. We compared outcomes of AL patients treated for relapse with DLI or second Allo-HCT after receiving debulking therapy. In total, 46 patients were included in the study; 30 (65%) had acute myeloid leukemia and 16 (35%) had acute lymphoblastic leukemia. The median age was 38 years (range 4-66). Twenty-seven patients received a second Allo-HCT and 19 patients received DLI. The median follow-up of the cohort was 273 days (range 9-7013). Overall survival (OS), disease-free surviv…

OncologyMaleCancer ResearchTransplantation Conditioningmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationKaplan-Meier EstimateCohort Studies0302 clinical medicineRecurrencehemic and lymphatic diseasesCumulative incidenceChildAcute leukemiaUnivariate analysisHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAllograftsLeukemiaLeukemia Myeloid Acutesurgical procedures operative030220 oncology & carcinogenesisChild PreschoolLymphocyte TransfusionFemaleLeukocyte Reduction ProceduresAdultmedicine.medical_specialtyAdolescentGraft vs Leukemia EffectDisease-Free Survival03 medical and health sciencesYoung AdultInternal medicineGeneticsmedicineHumansMolecular BiologyAgedRetrospective StudiesImmunosuppression TherapySalvage Therapybusiness.industryCell Biologymedicine.diseaseTransplantationbusiness030215 immunologyExperimental hematology
researchProduct

Humanized mice in cutaneous leishmaniasis—Suitability analysis of human PBMC transfer into immunodeficient mice

2019

Humanized mice represent a suitable preclinical test system for example therapeutic interventions in various disease settings, including infections. Here, we intended to establish such system for cutaneous leishmaniasis by infecting T, B and NK cell-deficient mice adoptively transferred with human peripheral blood mononuclear cells (PBMC). L major infection led to the establishment of parasite lesions harbouring viable parasites and human T cells, but parasite elimination was not seen due to a species-specific activity of T cell-derived human IFNγ. In addition, up to 50% of infected mice succumbed to severe graft-versus-host disease. In summary, even though long-term disease outcome assessm…

0301 basic medicineT cellGraft vs Host DiseaseLeishmaniasis CutaneousDermatologyDiseaseBiochemistryPeripheral blood mononuclear cellLesionInterferon-gammaMice030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSpecies SpecificityCutaneous leishmaniasisT-Lymphocyte SubsetsIn vivoAnimalsHumansMedicineParasite hostingMolecular Biologybusiness.industryMacrophagesLeishmaniasismedicine.diseaseAdoptive Transfer030104 developmental biologymedicine.anatomical_structureModels AnimalImmunologyDisease ProgressionLeukocytes MononuclearHeterograftsmedicine.symptombusinessExperimental Dermatology
researchProduct

Polymerization reactions and modifications of polymers by ionizing radiation

2020

International audience; Ionizing radiation has become the most effective way to modify natural and synthetic polymers through crosslinking, degradation, and graft polymerization. This review will include an in-depth analysis of radiation chemistry mechanisms and the kinetics of the radiation-induced C-centered free radical, anion, and cation polymerization, and grafting. It also presents sections on radiation modifications of synthetic and natural polymers. For decades, low linear energy transfer (LLET) ionizing radiation, such as gamma rays, X-rays, and up to 10 MeV electron beams, has been the primary tool to produce many products through polymerization reactions. Photons and electrons in…

Kinetic chain lengthMaterials sciencePolymers and PlasticsReview02 engineering and technologyDegree of polymerizationRadiation chemistryPhotochemistry01 natural scienceslcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistry0103 physical sciencesIrradiationradiation of natural polymerschemistry.chemical_classification010308 nuclear & particles physicsGeneral ChemistryPolymer[CHIM.MATE]Chemical Sciences/Material chemistryradiation induced polymerization021001 nanoscience & nanotechnologyradiation induced graftingIonizing radiation Radiation induced grafting Radiation induced polymerization Radiation of natural polymers Radiation synthesis nanogelsradiation synthesis nanogelsMonomer[CHIM.POLY]Chemical Sciences/PolymerschemistryPolymerizationRadiolysisSettore CHIM/07 - Fondamenti Chimici Delle Tecnologieionizing radiation0210 nano-technology
researchProduct

Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery.

2013

Background The purpose of this study was to analyze the long-term results of infrainguinal bypass surgery using the deep femoral artery (DFA) as the inflow source. Methods Between 1998 and 2011, 88 bypasses of the lower limb were placed in 86 patients (mean age 71 years) using the deep femoral artery as inflow. Patients' records were retrieved from a computerized database and analyzed retrospectively. Results Critical limb ischemia (rest pain/tissue loss) was the indication in the majority (87.5%) of cases. The distal anastomosis of the bypass grafts was located at the popliteal level in 32 cases and the tibial (pedal) level in 52 cases, respectively, with the autologous vein as conduit in …

Malemedicine.medical_specialtyTime FactorsInfrainguinal bypassCritical IllnessInflowFemoral arteryKaplan-Meier EstimateIschemiamedicine.arterymedicineDeep Femoral ArteryHumansVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesGroinbusiness.industryGeneral MedicineCritical limb ischemiaPerioperativeMiddle Agedmedicine.diseaseLimb SalvageSurgeryFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremitySurgeryVascular GraftingRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationAnnals of vascular surgery
researchProduct

Primary in vivo T cell reactivity of NZB grafts in H-2 identical allogenic hosts.

1983

By means of the Simonson GVH-assay and the popliteal lymph node (PLN) assay, the T-cell reactivity of NZB mice against H-2 identical allogenic cells was investigated in vivo and compared to that of normal mice. None of the normal mice did react, but a highly significant NZB response could be demonstrated, which did not depend on differences in Mls antigens. These in vivo results extend previous findings of a T-cell hyperreactivity of NZB mice in primary in vitro reactions. They favour the possibility that the T-cell hyperreactivity might be relevant in vivo in facilitating autoimmune responses.

T-LymphocytesImmunologychemical and pharmacologic phenomenaAutoimmune responsesBiologySerologyAutoimmune DiseasesMinor Lymphocyte Stimulatory AntigensGraft vs Host ReactionMiceIn vivoImmunology and AllergyAnimalsLymphocytesMice Inbred BALB CMice Inbred NZBH-2 AntigensT cell reactivityHematologyOrgan SizeIn vitroTransplantationMice Inbred C57BLKineticsLiverMice Inbred DBALymphocyte TransfusionImmunologyPopliteal Lymph NodeSpleenImmunobiology
researchProduct

MODIFICA SUPERFICIALE DI FILM DI POLY(ETILENE-co-ACIDO ACRILICO) CON NANOPARTICELLE DI SILICE ATTIVATA

2009

chemical surface modification hybrid materialsgrafting from grafting to silica nanoparticles
researchProduct

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-dr…

2017

Background Studying the intracellular distribution of pharmacological agents, including anticancer compounds, is of central importance in biomedical research. It constitutes a prerequisite for a better understanding of the molecular mechanisms underlying drug action and resistance development. Hyperactivated fibroblast growth factor receptors (FGFRs) constitute a promising therapy target in several types of malignancies including lung cancer. The clinically approved small-molecule FGFR inhibitor nintedanib exerts strong cytotoxicity in FGFR-driven lung cancer cells. However, subcellular pharmacokinetics of this compound and its impact on therapeutic efficacy remain obscure. Methods 3-dimens…

IndolesLung NeoplasmsNintedanibResistancelcsh:RC254-282FluorescenceMiceCell Line TumorAntineoplastic Combined Chemotherapy ProtocolsAnimalsHumansPhosphorylationLungCell ProliferationAntineoplastic Combined Chemotherapy ProtocolAnimalResearchDrug Synergismlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensLysosomeReceptors Fibroblast Growth FactorXenograft Model Antitumor AssaysLung NeoplasmFGFR1IndoleSettore CHIM/03 - Chimica Generale E InorganicaMacrolidesMacrolideLysosomesHumanSignal Transduction
researchProduct

Immobilisation of humic substances

2002

Attempts were made to immobilise humic substances (HS) by grafting them onto different carriers (styrene-divinylbenzene copolymers, cellulose and silica) as well as by their crosslinking with formaldehyde. Reaction with Merrifield resin was used for the immobilisation of HS, coupling by means of water-soluble carbodiimides to carriers containing amino-groups. Crosslinking of HS with formaldehyde (also in presence of other substances able to enter polycondensation reactions with formaldehyde) was shown to be an efficient method for their insolubilisation. Properties of the obtained immobilised HS were studied, including their potential use as sorbents for several metal ions and organic subst…

chemistry.chemical_compoundColloid and Surface ChemistryCondensation polymerAdsorptionChemistryMetal ions in aqueous solutionInorganic chemistryFormaldehydeCopolymerOrganic chemistryCelluloseGraftingMerrifield resinColloids and Surfaces A: Physicochemical and Engineering Aspects
researchProduct

Interferon-α Suppresses cAMP to Disarm Human Regulatory T Cells

2013

Abstract IFN-α is an antineoplastic agent in the treatment of several solid and hematologic malignancies that exerts strong immune- and autoimmune-stimulating activity. However, the mechanisms of immune activation by IFN-α remain incompletely understood, particularly with regard to CD4+CD25highFoxp+ regulatory T cells (Treg). Here, we show that IFN-α deactivates the suppressive function of human Treg by downregulating their intracellular cAMP level. IFN-α–mediated Treg inactivation increased CD4+ effector T-cell activation and natural killer cell tumor cytotoxicity. Mechanistically, repression of cAMP in Treg was caused by IFN-α–induced MAP–ERK kinase (MEK)/extracellular signal-regulated ki…

MAPK/ERK pathwayCancer Researchmedicine.medical_treatmentGraft vs Host DiseaseAutoimmunitychemical and pharmacologic phenomenaBiologyLymphocyte ActivationT-Lymphocytes RegulatoryNatural killer cellMiceImmune systemDownregulation and upregulationT-Lymphocyte SubsetsCyclic AMPmedicineAnimalsHumansIL-2 receptorPhosphorylationExtracellular Signal-Regulated MAP KinasesCells CulturedMitogen-Activated Protein Kinase KinasesInterleukin-2 Receptor alpha SubunitInterferon-alphaFOXP3hemic and immune systemsDNA-Binding ProteinsKiller Cells NaturalSTAT Transcription Factorsmedicine.anatomical_structureCytokineOncologyHumanized mouseImmunologyCancer researchCancer Research
researchProduct